Transdermal Drug Delivery System Market Is Expected To Reach $49.6 Billion By 2032

Zion Market Research has published a new report titled “Transdermal Drug Delivery System Market By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Others), and By End-User (Home Care Settings and Hospitals & Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032”. The global Transdermal Drug Delivery System market size accrued earnings worth approximately USD 33.32 Billion in 2023 and is predicted to gain revenue of about USD 49.60 Billion by 2032, is set to record a CAGR of nearly 4.52% over the period from 2024 to 2032.

Transdermal drug delivery systems deliver drugs via the skin to ensure a systemic drug circulation and maintain clinically effective concentrations at a predetermined rate over an estimated timeline. The substantial advancements in the biotechnology industry and improving capabilities of medical practitioners who use drugs at specific locations without causing skin rupture.

Browse the full “Transdermal Drug Delivery System Market By Type (Transdermal Patches and Transdermal Semisolids), By Application (Pain Management, Hormonal Applications, Central Nervous System Disorders, Cardiovascular Diseases, and Others), and By End-User (Home Care Settings and Hospitals & Clinics): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024–2032” Report at https://www.zionmarketresearch.com/report/transdermal-drug-delivery-system-market

The rising occurrences of chronic diseases and various technological developments in healthcare, pharmaceutical, and biotechnology sectors are boosting the transdermal drug delivery system market globally. Various applications of these systems are useful in hormonal disorders, pain management, central nervous system ailments, cardiovascular diseases, which will generate lucrative growth avenues for the transdermal drug delivery system market in the future. Some advantageous features like non-invasiveness, lower pain sensations in patients, and ease of treatment termination are also driving this market. However, these drug delivery systems have various disadvantages like irritation at the application site and edema, which may impede this global market.

The transdermal drug delivery system market is fragmented based on type, application, and end-user. By type, the market is divided into transdermal semisolids and transdermal patches. The transdermal patches are further segmented into reservoir membrane patches, matrix patches, drug-in-adhesive patches, and microneedle patches. The transdermal semisolids further include sprays, ointments, and gels. Transdermal patches accounted for the largest share in the global market in 2018, due to their several benefits like decreased dosing frequency, enhanced bioavailability, and ability of drug termination at any stage by simply removing the patch.

By application, the transdermal drug delivery system market includes cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and others. The hormonal applications segment is further classified into transdermal estrogen and testosterone replacement therapies. The pain management segment accounted for the largest share in the global market in 2018, due to the elevating burden of chronic pain globally and increasing accessibility of transdermal products for pain management.

The end-user segment of the market for transdermal drug delivery system is bifurcated into hospitals and clinics and home care settings. The home care settings segment accounted for the largest share in the global market in 2018.

North America accounted for the largest share in the global transdermal drug delivery system market in 2018 and is anticipated to remain dominant over the forecast time period as well. The Asia pacific transdermal drug delivery system market is expected to register the highest growth rate globally in the future.

Some key players in the transdermal drug delivery system market are GlaxoSmithKline, Novartis, Johnson & Johnson, Endo International, Purdue Pharma, Boehringer Ingelheim, Hisamitsu Pharmaceutical, Bristol-Myers Squibb, Mylan, and Bayer.

This report segments the global transdermal drug delivery system market into:

Global Transdermal Drug Delivery System Market: Type Analysis

• Transdermal Patches
  • Drug-In-Adhesive Patches
  • Matrix Patches
  • Reservoir Membrane Patches
  • Microneedle Patches
• Transdermal Semisolids
  • Gels
  • Ointments
  • Sprays

Global Transdermal Drug Delivery System Market: Application Analysis

• Pain Management
• Hormonal Applications
  • Testosterone Replacement Therapy
  • Transdermal Estrogen Therapy
• Central Nervous System Disorders
• Cardiovascular Diseases
• Other Applications

Global Transdermal Drug Delivery System Market: End-User Analysis

• Hospitals and Clinics
• Home Care Settings

Global Transdermal Drug Delivery System Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com